Trial Details

Not Recruiting
Basic Information
Clinical ID c4977
Identifier ISRCTN69447524
Trial Title The effect of combined n-3 polyunsaturated fatty acid and antioxidant dietary supplements on Crohn's disease & the associated osteoporosis, malnutrition and morbidity
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Digestive system diseases: Inflammatory bowel disease; Musculoskeletal diseases: Osteoporosis Digestive System Crohn's disease
Interventions 1. The dietary intervention consists of: 9 capsules per day of (Maxepa) fish oil (1.62 g of eicosapentaenoic acid, 1.08 g of docosahexanoic acid) and 1 capsule per day of antioxidant vitamins containing selenium 200 ug (reference nutrient intake [RNI] 75
Participant Information
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
City NULL
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL